Furthermore, we show a correlation between higher expression of Eomes in CD4+ Th cells in SPMS patients at the baseline measurement and clinical progression of the disease after one year, measured by changes in EDSS. This evidence concerns the gene EOMES and secondary progressive multiple sclerosis.